Neurosoft Bioelectronics Closes $7.5M Seed Round for Brain-Computer Interfaces
Neurosoft Bioelectronics has successfully closed a $7.5 million oversubscribed seed funding round aimed at scaling its innovative soft and stretchable brain-computer interface technology.
GENEVA & NEW YORK–(BUSINESS WIRE)–Neurosoft Bioelectronics closes $7.5M oversubscribed seed round to scale its soft, stretchable brain-computer interface platform.